Skip to main content

Advertisement

SpringerLink
Log in

Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A woman in her late 70 s was diagnosed with liver injury at a health examination. Despite treatment with ursodeoxycholic acid at a nearby hospital, her transaminase levels elevated in two peaks. She was transferred to our hospital 77 days after the health examination. She weighed 42 kg and had a low body mass index of 19.8 kg/m2. Viral markers, including immunoglobulin A (IgA) against hepatitis E virus (anti-HEV IgA), were negative. Drug-induced liver injury was negligible. We suspected autoimmune hepatitis because of the patient’s female gender and positive antinuclear antibody. However, prednisolone and azathioprine failed to completely improve her hepatitis. On day 643, anti-HEV IgA was re-evaluated and found to be positive. She was diagnosed with autochthonous chronic hepatitis E because the virus strains in the preserved serum on day 77 and the serum on day 643 had identical nucleotide sequences (genotype 3a). Following prednisolone and azathioprine discontinuation, ribavirin (RBV) was administered for 3 months. HEV RNA disappeared and remained negative for more than 6 months after the cessation of RBV. The HEV RNA titer of 6.2 log10 copies/mL on day 77 was unusually high 2.5 months after the onset, suggesting that hepatitis E had already been chronic before immunosuppressive treatment for possible autoimmune hepatitis. After getting married at 23 years old, she had been a housewife and had no comorbidities that might deteriorate her immunity. Chronicity should be kept in mind when encountering HEV infection in elderly and underweight patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis. 2003;9:448–54.

    Article  PubMed  Google Scholar 

  2. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002;40:117–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Takahashi M, Okamoto H. Features of hepatitis E virus infection in humans and animals in Japan. Hepatol Res. 2014;44:43–58.

    Article  PubMed  Google Scholar 

  4. Ticehurst JR, Pisanic N, Forman MS, et al. Probable transmission of hepatitis E virus (HEV) via transfusion in the United States. Transfusion. 2019;59:1024–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Satake M, Matsubayashi K, Hoshi Y, et al. Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression. Transfusion. 2017;57:280–8.

    Article  CAS  PubMed  Google Scholar 

  6. Yamazaki Y, Naganuma A, Arai Y, et al. Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015. Hepatol Res. 2017;47:435–45.

    Article  PubMed  Google Scholar 

  7. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–7.

    Article  CAS  PubMed  Google Scholar 

  8. Koenecke C, Pischke S, Beutel G, et al. Hepatitis E virus infection in a hematopoietic stem cell donor. Bone Marrow Transplant. 2014;49:159–60.

    Article  CAS  PubMed  Google Scholar 

  9. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150:430–1.

    Article  PubMed  Google Scholar 

  10. Bauer H, Luxembourger C, Gottenberg JE, et al. Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study. Medicine (Baltimore). 2015;94:e675.

    Article  CAS  PubMed  Google Scholar 

  11. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361:1025–7.

    Article  CAS  PubMed  Google Scholar 

  12. Grewal P, Kamili S, Motamed D. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology. 2014;59:347–8.

    Article  PubMed  Google Scholar 

  13. zu Siederdissen CH, Pischke S, Schlue J, et al. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology. 2014;60:1112–3.

    Article  Google Scholar 

  14. Wang Y, Liu S, Pan Q, Zhao J. Chronic hepatitis E in an immunocompetent patient. Clin Res Hepatol Gastroenterol. 2020;44:e66–8.

    Article  PubMed  Google Scholar 

  15. Colson P, Schleinitz N, Vely F, et al. Chronic hepatitis E in absence of severe immune deficiency. Clin Res Hepatol Gastroenterol. 2020;44:e1-4.

    Article  PubMed  Google Scholar 

  16. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.

    Article  CAS  PubMed  Google Scholar 

  17. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.

    Article  PubMed  Google Scholar 

  18. Takahashi M, Hoshino Y, Tanaka T, et al. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol. 2008;153:657–66.

    Article  CAS  PubMed  Google Scholar 

  19. Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol. 2005;43:49–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40:3209–18.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Inagaki Y, Oshiro Y, Tanaka T, et al. A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan. EBioMedicine. 2015;2:1607–12.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Owada Y, Oshiro Y, Inagaki Y, et al. A nationwide survey of hepatitis E virus infection and chronic hepatitis in heart and kidney transplant recipients in Japan. Transplantation. 2020;104:437–44.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kurihara T, Yoshizumi T, Itoh S, et al. Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report. Surg Case Rep. 2016;2:32.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Miyoshi M, Kakinuma S, Tanabe Y, et al. Chronic hepatitis E infection in a persistently immunosuppressed patient unable to be eliminated after ribavirin therapy. Intern Med. 2016;55:2811–7.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mitsui T, Tsukamoto Y, Suzuki S, et al. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals. J Med Virol. 2005;76:526–33.

    Article  CAS  PubMed  Google Scholar 

  26. Hasegawa I, Nakano T, Koguchi H, et al. Subclinical hepatitis E virus (HEV) infection detected by nucleic acid amplification test on blood donation: short-term positivity for immunoglobulin G class of antibody against HEV. Clin J Gastroenterol. 2022;15:750–4.

    Article  PubMed  Google Scholar 

  27. Liu G, Rusling JF. COVID-19 antibody tests and their limitations. ACS Sens. 2021;6:593–612.

    Article  CAS  PubMed  Google Scholar 

  28. Le Cann P, Tong MJ, Werneke J, et al. Detection of antibodies to hepatitis E virus in patients with autoimmune chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol. 1997;32:387–9.

    Article  PubMed  Google Scholar 

  29. Nagasaki F, Ueno Y, Mano Y, et al. A patient with clinical features of acute hepatitis E viral infection and autoimmune hepatitis. Tohoku J Exp Med. 2005;206:173–9.

    Article  PubMed  Google Scholar 

  30. Kanda T, Yasui S, Nakamura M, et al. Recent trend of hepatitis E virus infection in Chiba area, Japan: 3 of 5 cases with rheumatoid arthritis. Case Rep Gastroenterol. 2015;9:317–26.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gui H, Wang W, Li Q, Li Z, Lu J, Xie Q. Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection. Immunol Res. 2021;69:81–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Elfert KA, Qasim HM, Faisal MM, et al. Hepatitis E viral association with autoimmune hepatitis: a viral trigger or cross-reactivity. Case Rep Gastroenterol. 2021;15:115–22.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Takahashi M, Tanaka T, Azuma M, et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol. 2007;45:3671–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48:1368–75.

    Article  CAS  PubMed  Google Scholar 

  35. Matsui T, Kang JH, Matsubayashi K, et al. Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery. Hepatol Res. 2015;45:698–704.

    Article  CAS  PubMed  Google Scholar 

  36. Okano H, Nakano T, Ito R, et al. The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia. Clin J Gastroenterol. 2020;13:252–9.

    Article  PubMed  Google Scholar 

  37. Tanaka T, Akamatsu N, Sakamoto Y, et al. Treatment with ribavirin for chronic hepatitis E following living donor liver transplantation: a case report. Hepatol Res. 2016;46:1058–9.

    Article  PubMed  Google Scholar 

  38. Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of undernourished—a consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10:207–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Lesourd BM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr. 1997;66:478S-S484.

    Article  CAS  PubMed  Google Scholar 

  40. Peron JM, Danjoux M, Kamar N, et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France. Virchows Arch. 2007;450:405–10.

    Article  PubMed  Google Scholar 

  41. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–93.

    Article  CAS  PubMed  Google Scholar 

  42. Beer A, Holzmann H, Pischke S, et al. Chronic hepatitis E is associated with cholangitis. Liver Int. 2019;39:1876–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lenggenhager D, Pawel S, Honcharova-Biletska H, et al. The histologic presentation of hepatitis E reflects patients’ immune status and pre-existing liver condition. Mod Pathol. 2021;34:233–48.

    Article  CAS  PubMed  Google Scholar 

  44. Kamar N, Lhomme S, Abravanel F, et al. Treatment of HEV infection in patients with a solid-organ transplant and chronic hepatitis. Viruses. 2016;8:222.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481–9.

    Article  PubMed  Google Scholar 

  46. Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:1111–20.

    Article  CAS  PubMed  Google Scholar 

  47. Debing Y, Emerson SU, Wang Y, et al. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob Agents Chemother. 2014;58:267–73.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Todt D, Gisa A, Radonic A, et al. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut. 2016;65:1733–43.

    Article  CAS  PubMed  Google Scholar 

  49. Yamazaki Y, Uehara D, Kanayama Y, et al. Characteristics of cases of hepatitis E in 2019 in Gunma prefecture: a small epidemic caused by the same subgenotype 3a strain. Kanzo. 2020;61:478–81 ((in Japanese)).

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported in part by the Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED (to H.O., JP22fk0210075).

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, Kusunoki Hospital, 607-22 Fujioka, Fujioka, Gunma, 375-0024, Japan

    Satoshi Takakusagi, Hitoshi Takagi & Takashi Kosone

  2. Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-15 Showa-Machi, Maebashi, Gunma, 371-8511, Japan

    Yuichi Yamazaki

  3. Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Shigeo Nagashima, Masaharu Takahashi, Kazumoto Murata & Hiroaki Okamoto

Authors
  1. Satoshi Takakusagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hitoshi Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuichi Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Kosone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigeo Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaharu Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazumoto Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroaki Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hitoshi Takagi.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest in association with the present study.

Human/animal rights

All procedures followed were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent for the publication of this report was obtained from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takakusagi, S., Takagi, H., Yamazaki, Y. et al. Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment. Clin J Gastroenterol 16, 206–215 (2023). https://doi.org/10.1007/s12328-022-01733-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-022-01733-2

Keywords

Search

Navigation